NASDAQ:MMSI Merit Medical Systems (MMSI) Stock Price, News & Analysis $89.04 0.00 (0.00%) Closing price 08/7/2026 04:00 PM EasternExtended Trading$88.12 -0.92 (-1.03%) As of 08/7/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Merit Medical Systems Stock (NASDAQ:MMSI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Merit Medical Systems alerts:Sign Up Key Stats Today's Range$87.47▼$89.2750-Day Range$60.65▼$89.0452-Week Range$59.74▼$94.75Volume1.10 million shsAverage Volume1.08 million shsMarket Capitalization$5.32 billionP/E Ratio36.79Dividend YieldN/APrice Target$100.30Consensus RatingModerate Buy Company Overview Merit Medical Systems, Inc. is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy. Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach. Headquartered in South Jordan, Utah, the company operates manufacturing and distribution facilities in North America, Europe and Asia. Merit’s products are sold in over 90 countries worldwide, with regional sales offices in Europe, Latin America and the Asia‐Pacific region to support local clinical training and customer service. Under the leadership of founder and CEO Fred Lampropoulos, Merit Medical Systems has maintained a focus on innovation, quality and customer education. The company invests in research and development to evolve its product pipeline and partners with healthcare professionals to improve procedural outcomes. Merit’s commitment to minimally invasive care and patient safety has positioned it as a key supplier to hospitals and health systems seeking advanced device solutions for complex diagnostic and therapeutic procedures.AI Generated. May Contain Errors. Read More Merit Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreMMSI MarketRank™: Merit Medical Systems scored higher than 67% of companies evaluated by MarketBeat, and ranked 241st out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingMerit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 8 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialMerit Medical Systems has a consensus price target of $100.30, representing about 12.6% upside from its current price of $89.04.Amount of Analyst CoverageMerit Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Merit Medical Systems' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.40% Earnings GrowthEarnings for Merit Medical Systems are expected to grow by 8.40% in the coming year, from $3.81 to $4.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Merit Medical Systems is 36.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Merit Medical Systems is 36.79, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 270.57.Price to Earnings Growth RatioMerit Medical Systems has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMerit Medical Systems has a P/B Ratio of 3.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.81% of the float of Merit Medical Systems has been sold short.Short Interest Ratio / Days to CoverMerit Medical Systems has a short interest ratio ("days to cover") of 5.24.Change versus previous monthShort interest in Merit Medical Systems has recently increased by 1.42%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMerit Medical Systems does not currently pay a dividend.Dividend GrowthMerit Medical Systems does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.83 News SentimentMerit Medical Systems has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Merit Medical Systems this week, compared to 5 articles on an average week.Search Interest5 people have searched for MMSI on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Merit Medical Systems insiders have not sold or bought any company stock.Percentage Held by Insiders0.70% of the stock of Merit Medical Systems is held by insiders.Percentage Held by Institutions99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Merit Medical Systems' insider trading history. Receive MMSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MMSI Stock News HeadlinesMerit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of "Moderate Buy" by AnalystsAugust 8 at 2:28 AM | americanbankingnews.comMerit Medical (MMSI) Q2 2026 Earnings Call TranscriptAugust 8 at 2:12 AM | finance.yahoo.comForget SpaceX, Elon Is Now Powering the Next Hot IPOElon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 times faster than Nvidia, according to Jeff Brown of Brownstone Research. The company recently filed paperwork for what could become the next major IPO on Wall Street. Investors can explore how to claim a pre-IPO stake for as little as $50 before shares go public. | Brownstone Research (Ad)Merit Medical Systems to Participate in Upcoming Canaccord Genuity and Bank of America Investor ConferencesAugust 5, 2026 | quiverquant.comQMerit Medical to Participate in Upcoming Investors Conferences in AugustAugust 5, 2026 | globenewswire.comMMSI Q2 Deep Dive: Balanced Growth Across Platforms and Strategic Portfolio ExpansionAugust 4, 2026 | finance.yahoo.comMerit Medical Systems (NASDAQ:MMSI) Price Target Raised to $95.00August 3, 2026 | americanbankingnews.comMerit Medical Systems (NASDAQ:MMSI) Price Target Raised to $83.00August 3, 2026 | americanbankingnews.comSee More Headlines MMSI Stock Analysis - Frequently Asked Questions How have MMSI shares performed this year? Merit Medical Systems' stock was trading at $88.14 on January 1st, 2026. Since then, MMSI shares have increased by 1.0% and is now trading at $89.04. How were Merit Medical Systems' earnings last quarter? Merit Medical Systems, Inc. (NASDAQ:MMSI) released its earnings results on Thursday, July, 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems's revenue was up 9.5% on a year-over-year basis. Read the conference call transcript. Does Merit Medical Systems have any subsidiaries? Merit Medical Systems subsidiaries include these companies: Fibrovein Holdings Limited, Brightwater Medical Inc., Vascular Insights LLC, Cianna Medical Inc., DFINE Inc., BioSphere Medical SA, Alveolus Inc., and others. Who are Merit Medical Systems' major shareholders? Merit Medical Systems' top institutional investors include Bank of New York Mellon Corp (0.69%), Handelsbanken Fonder AB (0.34%), Assenagon Asset Management S.A. (0.23%) and Gradient Investments LLC (0.04%). Insiders that own company stock include Fred P Lampropoulos, A Scott Anderson, Joseph Wright, F Ann Millner, Raul Jr Parra, Thomas James Gunderson, Neil Peterson, Lynne N Ward, David Floyd, Stephen C Evans and Brian G Lloyd. View institutional ownership trends. How do I buy shares of Merit Medical Systems? Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Merit Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Merit Medical Systems investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and AUO (AUOTY). Company Calendar Last Earnings7/30/2026Today8/09/2026Canaccord Genuity's 46th Annual Growth Conference8/11/2026Bank of America SMID Cap Virtual Conference8/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 For the last 3 weeks, MMSI's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNASDAQ:MMSI CIK856982 Webwww.merit.com Phone(801) 253-1600Fax801-253-1652Employees7,500Year Founded1987Price Target and Rating Average Price Target for Merit Medical Systems$100.30 High Price Target$114.00 Low Price Target$83.00 Potential Upside/Downside+12.6%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$2.42 Trailing P/E Ratio36.79 Forward P/E Ratio23.37 P/E Growth2.24Net Income$128.49 million Net Margins9.22% Pretax Margin12.32% Return on Equity13.75% Return on Assets8.10% Debt Debt-to-Equity Ratio0.44 Current Ratio4.20 Quick Ratio2.79 Sales & Book Value Annual Sales$1.52 billion Price / Sales3.51 Cash Flow$5.88 per share Price / Cash Flow15.15 Book Value$26.72 per share Price / Book3.33Miscellaneous Outstanding Shares59,710,000Free Float59,292,000Market Cap$5.32 billion OptionableOptionable Beta0.48 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:MMSI) was last updated on 8/10/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredI’ll Keep This Short… (Huge AI Opportunity)Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - ...Traders Agency | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredFree Stock Pick: The Company First in Line for America’s New Super FuelThe U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...Banyan Hill Publishing | SponsoredALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merit Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merit Medical Systems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
